‘Weight loss’ drug semaglutide linked to better heart health

The weight loss drug semaglutide delivers cardiovascular benefits irrespective of starting weight and amount of weight lost, according to preliminary findings from a research team led by Professor John Deanfield (UCL Institute of Cardiovascular Science).

Read: BBC News; More: The Guardian, The Times (1) (£), The Times (2) (£), Daily Mail (1), Daily Mail (2), Daily Mail (3), Daily Mail (4), Express, New Scientist (£), iNews (1) (£), iNews (2) (£), iNews (3) (£), iNews (4) (£),  The Telegraph (£), Independent, Metro, Evening Standard (1), Evening Standard (2), The Herald, The Scotsman, Newsweek, Reuters, The Sun, ITV News, Sky News, GB News, Bloomberg,  Irish Times, Daily Record, Wales Online, Mirror (1), Mirror (2), Mirror (3), Mirror (4), US News & World Report, The Detroit News (USA), Forbes, New York Times Post, EuroNews, Medscape, ; Listen: BBC Radio 4 ‘Today’ (from 33 min, 34 sec), BBC World Service ‘Newsday’ (from 35 min, 54 sec), BBC Radio 2 (from 1 hr, 57 min, 25 sec), BBC Radio 2 ‘Jeremy Vine’ (from 4 min, 13 sec); Watch: BBC Breakfast (from 39 min, 52 sec), ITV ‘Good Morning Britain’ (from 5 min, 2 sec), ITV ‘Loose Women’ (from 7 min, 36 sec), BBC News at One (from 9 min, 49 sec); Channel 4 News, UCL News